Bloomberg Daybreak: August 7, 2019 – Hour 1 (Radio). August 7, 2019 — 3:12 AM PDT. Share on FacebookShare on Twitter · Share on
See Original Article

Phase 3 trials of Rhythm Pharmaceuticals’ setmelanotide in patients with genetic obesity have met their primary endpoints. Rhythm plans to use the data to complete a rolling submission to the FDA around the end of the year, positioning it to bring the drug to …
See Original Article

Vicki Goetter has joined Dalby, Wendland & Co. as chief operating officer of the Grand Junction-based accounting and business consulting firm.
See Original Article

“Holy hell!” a member of the FT editorial team screamed across the newsroom late last August 7. It was a balmy summer evening, and the paper had just broken a big story — Saudi Arabia’s investment fund had invested $2bn in electric car company Tesla …
See Original Article

Denning writes about energy for Bloomberg Opinion in New York. This column doesn't necessarily reflect the opinion of Bloomberg LP and its owners.
See Original Article